Conmed (CNMD) Net Income towards Common Stockholders Growth (3y) (2013 - 2026)
Conmed (CNMD) Net Income towards Common Stockholders Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn | -12.28% |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn | 20.02% |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 1.93% |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | 51.47% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -7.83% |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn | 29.05% |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn | 11.15% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 1,825.47% |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn | 17.54% |
| 10 | Conmed | 1.55 Bn | 1.51 Bn | 197.46 Mn | 18.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18.88% |
| Mar 31, 2026 | 96.63% |
| Dec 31, 2025 | -14.29% |
| Sep 30, 2025 | -60.43% |
| Jun 30, 2025 | 28.61% |
| Mar 31, 2025 | -26.13% |
| Dec 31, 2024 | 11.36% |
| Sep 30, 2024 | 48.53% |
| Jun 30, 2024 | 31.14% |
| Mar 31, 2024 | 25.97% |
| Dec 31, 2023 | 31.60% |
| Sep 30, 2023 | 32.23% |
| Jun 30, 2023 | 35.74% |
| Mar 31, 2023 | -32.55% |
| Dec 31, 2022 | 21.19% |
| Sep 30, 2022 | 87.78% |
| Jun 30, 2022 | -215.99% |
| Mar 31, 2022 | 144.78% |
| Dec 31, 2021 | 16.02% |
| Sep 30, 2021 | 36.91% |